Bajelot, Dwyane Derrick Jim M.
HRN: 19-66-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
CEFUROXIME 750MG (VIAL)
10/21/2022
10/28/2022
IV
300mg
Q8h
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes